insights_auto
Why is AVE down 11,11%?
Dive Deeperchevron_right
AVE:ASX
Avecho Biotechnology Ltd
0,016 A$
arrow_downward
-11,11%(-0,0020) 1D
9 қаз., 16:10:30 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AVE...
Open
0,02 A$
High
0,02 A$
Low
0,02 A$
Mkt. cap
61,82 млн
Avg. vol.
2,82 млн
Volume
7,77 млн
52-wk high
0,03 A$
52-wk low
0,00 A$
EPS
-0,00 A$
Shares outstanding
3,86 млрд
No. of employees
15
Open
0,02 A$
High
0,02 A$
Low
0,02 A$
Mkt. cap
61,82 млн
Avg. vol.
2,82 млн
Volume
7,77 млн
52-wk high
0,03 A$
52-wk low
0,00 A$
EPS
-0,00 A$
Shares outstanding
3,86 млрд
No. of employees
15
News stories
From web sources and news partners
pharmaphorum
·
58 минут бұрын
Iambic prices its IPO, seeking to raise up to $160m
Yahoo Finance
·
1 сағат бұрын
Scancell revs up for Nasdaq listing as cancer vaccine developer prepares phase III melanoma trial
Seeking Alpha
·
51 минут бұрын
S&P 500 Sector Outlook: Favor XLC And XLK, Underweight XLP With Uneven Earnings Leadership
About Avecho Biotechnology Ltd
CEOPaul Gavin Ph.D.
Employees15
Founded1992
Headquarters-
SectorPharmaceutical industry
Websiteavecho.com.au